Stock analysis, AI verdict, fundamentals & technical signals
Rating: NEUTRAL
Price: $4.69 Analyst target: $8.50 Upside: 81.24%
Cumberland Pharmaceuticals Inc., a specialty pharmaceutical company, focuses on the acquisition, development, and marketing of prescription products for hospital acute care, gastroenterology, and rheumatology in the United States and internationally. The company is headquartered in Nashville, Tennessee.
See the full interactive analysis & chart →Informational only — not investment advice.